Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline
2022 · Nature Medicine · 457 citations
https://doi.org/10.1038/s41591-022-02049-x
V
Vincent Doré
Austin Health(AU)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
425
Papers
9.4K
Citations
45
h-index
105
i10-index
Vincent Doré is an academic researcher from Austin Health. The author has contributed to research in topics: Dementia and Cognitive Impairment Research & Alzheimer's disease research and treatments & Medical Imaging Techniques and Applications. The author has an h-index of 45, co-authored 362 publications.
ORCID: 0000-0002-8051-0558Papers by this author
worksRisk prediction of late-onset Alzheimer’s disease implies an oligogenic architecture
2020 · Nature Communications · 279 citations
https://doi.org/10.1038/s41467-020-18534-1
Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal study
2016 · The Lancet Neurology · 216 citations
https://doi.org/10.1016/s1474-4422(16)30125-9
Centiloid scaling for quantification of brain amyloid with [18F]flutemetamol using multiple processing methods
2018 · EJNMMI Research · 116 citations
https://doi.org/10.1186/s13550-018-0456-7
Relationship between amyloid and tau levels and its impact on tau spreading
2021 · European Journal of Nuclear Medicine and Molecular Imaging · 96 citations
https://doi.org/10.1007/s00259-021-05191-9
Early detection of amyloid load using 18F-florbetaben PET
2021 · Alzheimer s Research & Therapy · 70 citations
https://doi.org/10.1186/s13195-021-00807-6
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat